These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6506704)

  • 21. [The effect of hemosorption on the lipid and lipoprotein composition of the blood plasma].
    Perepelitsa VN
    Vrach Delo; 1990 Jun; (6):32-4. PubMed ID: 2399714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(12):1682-4. PubMed ID: 6686774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Disorders in blood lipid concentration in patients with myocardial infarction with xanthomatosis and lipid changes in the soft palate].
    Markiewicz M; Dubejko J; Michałowski R; Kutarski A
    Pol Tyg Lek; 1982 Aug; 37(29-30):851-4. PubMed ID: 7155972
    [No Abstract]   [Full Text] [Related]  

  • 24. Familial hypercholesterolemia: mechanism of inheritance.
    de Oya M; Nuno J; Azpeitia AG; Villasante JG
    Diabete Metab; 1980 Sep; 6(3):181-8. PubMed ID: 7439491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of procetofen on the lipoprotein profile in patients with type II hyperlipoproteinemia].
    Drouin P; Méjean L; Lambert D; Sauvanet JP; Debry G
    Med Welt; 1979 Dec; 30(50):1910-3. PubMed ID: 548697
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood plasma prostaglandins and their role in disorders of lipid metabolism in ischemic heart disease caused by coronary arteriosclerosis].
    Bochkareva EV; Zykova VP; Lobova NM; Polesskiĭ VA; Gadzhanova SI
    Ter Arkh; 1980; 52(5):18-22. PubMed ID: 7404361
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum lipids and lipoproteins in arteriosclerosis obliterans of the lower extremities.
    Berezovsky LA; de Wolfe VG; Lewis LA
    Medicina (B Aires); 1978; 38(6 Pt 1):652-8. PubMed ID: 750857
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute effects of LDL-apheresis on cholesterol oxidation products and antioxidants in plasma and lipoproteins of patients with familial hypercholesterolemia.
    Linseisen J; Wilhelm M; Hoffmann J; Hailer S; Keller C; Wolfram G
    Eur J Med Res; 1999 Oct; 4(10):433-41. PubMed ID: 10527957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Protein sulfhydryl groups of blood serum and their relation to the indicators of lipid metabolism in patients with psoriasis].
    Kostiushov VV
    Vrach Delo; 1975 Jan; (1):116-8. PubMed ID: 1136343
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia.
    Lowe GD; Drummond MM; Third JL; Bremner WF; Forbes CD; Prentice CR; Lawrie TD
    Thromb Haemost; 1980 Feb; 42(5):1503-7. PubMed ID: 7368154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperlipidemia and arteriosclerosis. Prebetalipoproteinemia (based on 70 patients and 20 controls)].
    Loeper J; Rouffy J
    Rev Atheroscler (Paris); 1968; 10(3):30-43. PubMed ID: 5746500
    [No Abstract]   [Full Text] [Related]  

  • 33. [Coronary disease risk factors in myocardial infarct associated with lipid changes in the soft palate].
    Markiewicz M; Dubejko J; Michałowski R; Kutarski A
    Wiad Lek; 1980 Oct; 33(19):1517-23. PubMed ID: 7467323
    [No Abstract]   [Full Text] [Related]  

  • 34. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol].
    Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z
    Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in plasma lipoproteins from first day to third week of human life.
    Andersen GE
    Prog Clin Biol Res; 1985; 188():87-91. PubMed ID: 4059261
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lipoproteins].
    Yamamoto A; Yamamura T; Taka-Ich S
    Rinsho Byori; 1983 Aug; 31(8):863-73. PubMed ID: 6655919
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
    Ditschuneit HH; Hutt V; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1980; 30(11b):2063-7. PubMed ID: 7194061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia].
    Tvorogova MG; Rozhkova TA; Semenova OA; Lupanov VP; Nuraliev EIu ; Kukharchuk VV; Titov VN
    Ter Arkh; 1997; 69(12):30-3. PubMed ID: 9503530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.
    Pons P; Rodríguez M; Robaina C; Illnait J; Más R; Fernández L; Fernández JC
    Int J Clin Pharmacol Res; 1994; 14(1):27-33. PubMed ID: 7927958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.